Indoco Remedies informs about disclosure

25 Feb 2025 Evaluate

With reference to its letter dated 03rd December, 2024, wherein it was, informed that the Company, had received Show Cause Notice (SCN) on 02nd December, 2024 from the Goods and Service Tax (GST) Authority on account of various issues like excess claim of ITC, GSTR9C issue, etc. Further to the aforesaid, Indoco Remedies has informed that the said SCN was duly replied by the Company and the Deputy Commissioner (ST) STU-2 Malkajgiri Division Hyderabad Commercial Tax department Telangana vide its Order dated 24th February, 2025 has dropped the proceeding against the Company under the said SCN. The relevant details as per the requirement of Regulation 30 of the Listing Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024, amended from time to time is enclosed in ‘Annexure - A’.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

233.30 1.20 (0.52%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...